Cigna Group $CI Shares Sold by Avantra Family Wealth Inc.

Avantra Family Wealth Inc. lowered its position in Cigna Group (NYSE:CI) by 5.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,399 shares of the health services provider’s stock after selling 86 shares during the quarter. Avantra Family Wealth Inc.’s holdings in Cigna Group were worth $462,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its stake in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Cigna Group by 0.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock valued at $3,834,493,000 after purchasing an additional 98,715 shares during the period. Dodge & Cox increased its stake in shares of Cigna Group by 1.3% in the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock valued at $2,924,722,000 after purchasing an additional 117,125 shares during the period. GQG Partners LLC increased its stake in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Valeo Financial Advisors LLC increased its stake in shares of Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE CI opened at $303.30 on Tuesday. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market capitalization of $80.96 billion, a PE ratio of 16.56, a P/E/G ratio of 0.91 and a beta of 0.45. The company’s 50 day simple moving average is $292.64 and its 200 day simple moving average is $309.56.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the business earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group’s payout ratio is 32.97%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $365.00 price target on shares of Cigna Group in a research note on Tuesday, August 26th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday. Barclays raised their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a research note on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $371.81.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.